An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy - Orthogate

Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.

Details: By ClinicalTrials.gov; Joint Diseases; 10 July 2013

Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 200 mg; Drug: CNTO 6785 100 mg; Drug: CNTO 6785 50 mg; Drug: CNTO 6785 15 mg
Sponsors

Editor-in-Chief

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies